Medpace Holdings Inc vs Pinterest Inc — how do they compare? Medpace Holdings Inc trades at $533.71 (market cap $15.08B), while Pinterest Inc trades at $22.86 (market cap $12.78B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | PINS | |
|---|---|---|
Market Cap | $15.08B | $12.78B |
Sector | Technology | Media |
52-Week High | $620.59 | $39.17 |
52-Week Low | $308.88 | $15.42 |
Enterprise Value | $14.55B | $12.68B |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Pinterest (PINS) trades at $22.98, down 0.95% on the day, with technical indicators showing a bullish trend supported by moving averages. The company reported strong revenue growth, reaching $4.22B in 2025 with improving profitability margins. Recent news highlights director stock sales and upcoming Q2 2026 earnings, while analyst consensus remains positive with a $27.53 price target.
PINS presents a growth opportunity with solid fundamentals and bullish technicals, though risks include competitive pressures and insider selling. The stock trades below analyst targets, offering potential upside if earnings momentum continues. Key catalysts include Q2 results and e-commerce integration progress.
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →